Cite Filings / DNLI / 0001950047-24-010114
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Denali Therapeutics Inc. · Filed 2024-12-31 · Acc 0001950047-24-010114

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-01-07 4 Chief Medical Officer acquired 54,180 shares (grant or award)
  • 2025-01-03 4 Director sold 30,000 shares at $20.25 ($607,500)
  • 2025-01-03 4 Director sold 3,080 shares at $20.91 ($64,403)
  • 2025-01-02 144 Sale of Securities
  • 2024-12-31 144 Sale of Securities
  • 2024-12-31 4 COFO and Secretary acquired 6,708 shares (option exercise)
  • 2024-11-12 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…